1-Butyl-4-phenylpiperidine | 1334476-51-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-Butyl-4-phenylpiperidine
• CAS: 1334476-51-5
• 化学式: C₁₅H₂₃N
• 分子量: 217.354
• InChiKey: RLEMXRNFKKOCQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-苯基哌啶 、 正丁醛 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 为溶剂， 20.0 ℃ 、303.99 kPa 条件下， 反应 18.0h， 以67%的产率得到1-Butyl-4-phenylpiperidine
  参考文献：
  名称：

  使用Pd / C催化加氢的简单还原胺化反应合成新型血清素能药物和其他N-烷基胺

  摘要：

  N-烷基化的α-甲基色胺衍生物（2）的形成是通过在催化氢化条件下（3 atm H 2和碳上含10％Pd ）对胺（1）进行简单的胺酮还原胺化而完成的。该方法也适用于使用酮和醛的其他伯胺和仲胺。

  DOI：

  10.1016/j.tetlet.2011.07.058

文献信息

• [EN] HIGHLY SELECTIVE ELECTROCHEMICAL HYDROGENATION OF ALKYNES<br/>[FR] HYDROGÉNATION ÉLECTROCHIMIQUE HAUTEMENT SÉLECTIVE D'ALCYNES
  申请人：UNIV INDIANA TRUSTEES

  公开号：WO2020198464A1

  公开（公告）日：2020-10-01

  Disclosed are electrochemical methods to prepare an alkane or an alkene, such as a cis- alkene, from an alkyne, or an alkane from an alkene. The method utilizes an electrochemical cell having a cathode and an anode and a reactor.

  揭示了一种利用电化学方法从炔烃制备烷烃或烯烃（如顺式烯烃），或者从烯烃制备烷烃的方法。该方法利用具有阴极、阳极和反应器的电化学电池。
• Carbostyril compound
  申请人：Kuroda Takeshi

  公开号：US20070179173A1

  公开（公告）日：2007-08-02

  The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R 4 and R 5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R 1 is a hydrogen atom, etc; R 2 is a hydrogen atom, etc; and R 3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.

  本发明提供了一种由通式（1）表示的碳基噻吩化合物或其盐，其中A是直接键，较低的烷基烷基或较低的烷基亚烷基；X是氧原子或硫原子；R4和R5分别表示氢原子；碳基噻吩骨架的3和4位之间的键是单键或双键；R1是氢原子等；R2是氢原子等；R3是氢原子等。本发明的碳基噻吩化合物或其盐能够诱导TFF的产生，因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和伤口等疾病。
• QUINOLINE-4-CARBOXAMIDE AS NK-2 AND NK-3 RECEPTOR ANTAGONISTS
  申请人：Giardina Arnaldo Maria Giuseppe

  公开号：US20070197546A1

  公开（公告）日：2007-08-23

  A compound, or a solvate or a salt thereof, of formula (I): wherein, Ar is an optionally substituted aryl or a C 5-7 cycloalkdienyl group, or a C 5-7 cycloalkyl group or an optionally substituted single or fused ring aromatic heterocyclic group,; R is C 1-6 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkylalkyl, optionally substituted phenyl or phenyl C 1-6 alkyl, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatoms selected from O and N, hydroxy C 1-6 alkyl, amino C 1-6 alkyl, C 1-6 alkylaminoalkyl, di C 1-6 alkylaminoalkyl, C 1-6 acylaminoalkyl, C 1-6 alkoxyalkyl, C 1-6 alkylcarbonyl, carboxy, C 1-6 alkoxycarbonyl, C 1-6 alkoxycarbonyl C 1-6 alkyl, aminocarbonyl, C 1-6 alkylaminocarbonyl, di C 1-6 alkylaminocarbonyl, halogeno C 1-6 alkyl; or R is a group —(CH 2 ) p — wherein p is 2 or 3 which group forms a ring with a carbon atom of Ar; R 1 represents hydrogen or up to four optional substituents selected from the list consisting of: C 1-6 alkyl, C 1-6 alkenyl, aryl, C 1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, C 1-6 alkoxycarbonyl, trifluoromethyl, acyloxy, phthalimido, amino or mono- and di-C 1-6 alkylamino; R 2 represents a moiety —(CH 2 ) n —NY 1 Y 2 wherein n is an integer in the range of from 1 to 9, Y 1 and Y 2 are independently selected from hydrogen; C 1-6 -alkyl; C 1-6 alkyl substituted with hydroxy, C 1-6 alkylamino or bis (C 1-6 alkyl) amino; C 1-6 -alkenyl; aryl or aryl-C 1-6 -alkyl or Y 1 and Y 2 together with the nitrogen atom to which they are attached represent an optionally substituted N-linked single or fused ring heterocyclic group; R 3 is branched or linear C 1-6 alkyl, C 3-7 cycloalkyl, C 4-7 cycloalkylalkyl, optionally substituted aryl, or an optionally substituted single or fused ring aromatic heterocyclic group; and R4 represents hydrogen or C 1-6 alkyl; a pharmaceutical composition comprising such a compound, process for preparing such a compound and the use of such a compound in medicine.

  化合物，或其溶剂化合物或盐，其化学式为（I）：其中，Ar是可选择取代的芳基或C5-7环烯基基团，或C5-7环烷基团或可选择取代的单环或融合环芳杂环基团；R是C1-6烷基，C3-7环烷基，C3-7环烷基烷基，可选择取代的苯基或苯基C1-6烷基，包含最多四个杂原子（O和N）的可选择取代的五元杂环芳香环，羟基C1-6烷基，氨基C1-6烷基，C1-6烷基氨基烷基，二C1-6烷基氨基烷基，C1-6酰胺基烷基，C1-6烷氧基烷基，C1-6烷基羰基，羧基，C1-6烷氧羰基，C1-6烷氧羰基C1-6烷基，氨基羰基，C1-6烷基氨基羰基，二C1-6烷基氨基羰基，卤代C1-6烷基；或R是一个基团-（CH2）p-，其中p为2或3，该基团与Ar的一个碳原子形成环；R1表示氢或最多四个可选择的取代基，选自以下列表：C1-6烷基，C1-6烯基，芳基，C1-6烷氧基，羟基，卤素，硝基，氰基，羧基，羧酰胺基，磺酰胺基，C1-6烷氧羰基，三氟甲基，酰氧基，邻苯二甲酰亚胺基，氨基或单-和二-C1-6烷基氨基；R2表示一个基团-（ ）n-NY1Y2，其中n是1到9的整数，Y1和Y2独立选择自氢，C1-6烷基，C1-6烷基取代羟基，C1-6烷基氨基或双（C1-6烷基）氨基，C1-6烯基，芳基或芳基-C1-6烷基，或Y1和Y2与它们所连接的氮原子一起表示可选择取代的N-连接单环或融合环杂环基团；R3是支链或线性C1-6烷基，C3-7环烷基，C4-7环烷基烷基，可选择取代的芳基，或可选择取代的单环或融合环芳杂环基团；R4表示氢或C1-6烷基；包括这种化合物的药物组合物，制备这种化合物的方法以及在医学上使用这种化合物的用途。
• CARBOSTYRIL COMPOUND
  申请人：Kuroda Takeshi

  公开号：US20100261705A1

  公开（公告）日：2010-10-14

  The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R 4 and R 5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R 1 is a hydrogen atom, etc; R 2 is a hydrogen atom, etc; and R 3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.

  本发明提供了一种由通式（1）表示的羧基苯基咔唑化合物或其盐，其中A表示直接键，较低的烷基烷基或较低的烷基亚甲基烷基；X表示氧原子或硫原子；R4和R5各代表氢原子；羧基苯基咔唑骨架的3和4位置之间的键是单键或双键；R1是氢原子等；R2是氢原子等；R3是氢原子等。本发明的羧基苯基咔唑化合物或其盐可诱导TFF的产生，因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和创伤等疾病。
• US7777038B2
  申请人：——

  公开号：US7777038B2

  公开（公告）日：2010-08-17